Literature DB >> 25034147

Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.

J Ojha1, C Secreto2, K Rabe2, J Ayres-Silva3, R Tschumper2, D V Dyke2, S Slager2, R Fonseca1, T Shanafelt2, N Kay2, E Braggio1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25034147      PMCID： PMC4302736          DOI： 10.1038/leu.2014.226

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.

Authors:  Paolo Ghia; Giuseppina Prato; Cristina Scielzo; Stefania Stella; Massimo Geuna; Giuseppe Guida; Federico Caligaris-Cappio
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

2.  Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis.

Authors:  Silvia Rasi; Sara Monti; Valeria Spina; Robin Foà; Gianluca Gaidano; Davide Rossi
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

3.  B-cell clones as early markers for chronic lymphocytic leukemia.

Authors:  Ola Landgren; Maher Albitar; Wanlong Ma; Fatima Abbasi; Richard B Hayes; Paolo Ghia; Gerald E Marti; Neil E Caporaso
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

Review 4.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.

Authors:  T D Shanafelt; P Ghia; M C Lanasa; O Landgren; A C Rawstron
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

5.  Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Scott L Carter; Petar Stojanov; Aaron McKenna; Kristen Stevenson; Michael S Lawrence; Carrie Sougnez; Chip Stewart; Andrey Sivachenko; Lili Wang; Youzhong Wan; Wandi Zhang; Sachet A Shukla; Alexander Vartanov; Stacey M Fernandes; Gordon Saksena; Kristian Cibulskis; Bethany Tesar; Stacey Gabriel; Nir Hacohen; Matthew Meyerson; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

6.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors:  Lili Wang; Michael S Lawrence; Youzhong Wan; Petar Stojanov; Carrie Sougnez; Kristen Stevenson; Lillian Werner; Andrey Sivachenko; David S DeLuca; Li Zhang; Wandi Zhang; Alexander R Vartanov; Stacey M Fernandes; Natalie R Goldstein; Eric G Folco; Kristian Cibulskis; Bethany Tesar; Quinlan L Sievers; Erica Shefler; Stacey Gabriel; Nir Hacohen; Robin Reed; Matthew Meyerson; Todd R Golub; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  N Engl J Med       Date:  2011-12-12       Impact factor: 91.245

7.  Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies.

Authors:  Gerald E Marti; Youn K Shim; Maher Albitar; Dan Middleton; Fatima Abbasi; Ayana Anderson; Robert F Vogt
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

8.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Authors:  Víctor Quesada; Laura Conde; Neus Villamor; Gonzalo R Ordóñez; Pedro Jares; Laia Bassaganyas; Andrew J Ramsay; Sílvia Beà; Magda Pinyol; Alejandra Martínez-Trillos; Mónica López-Guerra; Dolors Colomer; Alba Navarro; Tycho Baumann; Marta Aymerich; María Rozman; Julio Delgado; Eva Giné; Jesús M Hernández; Marcos González-Díaz; Diana A Puente; Gloria Velasco; José M P Freije; José M C Tubío; Romina Royo; Josep L Gelpí; Modesto Orozco; David G Pisano; Jorge Zamora; Miguel Vázquez; Alfonso Valencia; Heinz Himmelbauer; Mónica Bayés; Simon Heath; Marta Gut; Ivo Gut; Xavier Estivill; Armando López-Guillermo; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

9.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Authors:  Andy C Rawstron; Fiona L Bennett; Sheila J M O'Connor; Marwan Kwok; James A L Fenton; Marieth Plummer; Ruth de Tute; Roger G Owen; Stephen J Richards; Andrew S Jack; Peter Hillmen
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

10.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.

Authors:  Laura Pasqualucci; Mara Compagno; Jane Houldsworth; Stefano Monti; Adina Grunn; Subhadra V Nandula; Jon C Aster; Vundavally V Murty; Margaret A Shipp; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2006-02-20       Impact factor: 14.307
View more
  25 in total

1.  Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.

Authors:  M Klinger; J Zheng; K S J Elenitoba-Johnson; S L Perkins; M Faham; D W Bahler
Journal:  Leukemia       Date:  2015-12-21       Impact factor: 11.528

Review 2.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

3.  Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.

Authors:  Juhi Ojha; Jackline Ayres; Charla Secreto; Renee Tschumper; Kari Rabe; Daniel Van Dyke; Susan Slager; Tait Shanafelt; Rafael Fonseca; Neil E Kay; Esteban Braggio
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

Review 4.  Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Authors:  Paolo Strati; Tait D Shanafelt
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

Review 5.  Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia.

Authors:  Romain Guièze; Catherine J Wu
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

Review 6.  Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

7.  Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

Authors:  Nils Winkelmann; Matthew Rose-Zerilli; Jade Forster; Marina Parry; Anton Parker; Anne Gardiner; Zadie Davies; Andrew J Steele; Helen Parker; Nicholas C P Cross; David G Oscier; Jonathan C Strefford
Journal:  Haematologica       Date:  2015-02-20       Impact factor: 9.941

8.  A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion.

Authors:  Shanye Yin; Rutendo G Gambe; Jing Sun; Aina Zurita Martinez; Zachary J Cartun; Fara Faye D Regis; Youzhong Wan; Jean Fan; Angela N Brooks; Sarah E M Herman; Elisa Ten Hacken; Amaro Taylor-Weiner; Laura Z Rassenti; Emanuela M Ghia; Thomas J Kipps; Esther A Obeng; Carrie L Cibulskis; Donna Neuberg; Dean R Campagna; Mark D Fleming; Benjamin L Ebert; Adrian Wiestner; Ignaty Leshchiner; James A DeCaprio; Gad Getz; Robin Reed; Ruben D Carrasco; Catherine J Wu; Lili Wang
Journal:  Cancer Cell       Date:  2019-01-31       Impact factor: 31.743

9.  Clonal dynamics in chronic lymphocytic leukemia.

Authors:  Catherine Gutierrez; Catherine J Wu
Journal:  Blood Adv       Date:  2019-11-26

10.  EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Authors:  E Young; D Noerenberg; L Mansouri; V Ljungström; M Frick; L-A Sutton; S J Blakemore; J Galan-Sousa; K Plevova; P Baliakas; D Rossi; R Clifford; D Roos-Weil; V Navrkalova; B Dörken; C A Schmitt; K E Smedby; G Juliusson; B Giacopelli; J S Blachly; C Belessi; P Panagiotidis; N Chiorazzi; F Davi; A W Langerak; D Oscier; A Schuh; G Gaidano; P Ghia; W Xu; L Fan; O A Bernard; F Nguyen-Khac; L Rassenti; J Li; T J Kipps; K Stamatopoulos; S Pospisilova; T Zenz; C C Oakes; J C Strefford; R Rosenquist; F Damm
Journal:  Leukemia       Date:  2016-11-28       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.